Company / FCF Margin
Coherus Oncology, Inc. FCF Margin History
FY2014-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-13165.8%
FY2017
5-year range
-13165.8% / 547.1%
FY2014-FY2017
Trend
-15194.8%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -15195% YoY in FY2017, a notable deviation from the 3-year average annual change of -5053%.
Based on SEC 10-K filings.
-13165.8% in FY2017 with a 3-year CAGR of -12110.8%.
Declined from 547.1% to -13165.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -12110.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2017, fcf margin decreased 15194.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -13165.8% | -15194.8% |
| FY2016 | -86.1% | -115.7% |
| FY2015 | 547.1% | +151.9% |
| FY2014 | -1055.0% | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026